SCUBE in human diseases: A systematic review

Abstract

The involvement of the Signal peptide-complement components of C1r/C1s, the sea urchin Uegf and Bone Morphogenetic Protein (CUB) domain-Epidermal Growth Factor (EGF)-related (SCUBE) gene in human diseases has been progressively apparent. The SCUBE1 is detectable in platelet-aggregation diseases. The SCUBE2 is reported to have a better cancer survival prognosis. However, SCUBE3 is detected in bone-related diseases. SCUBE gene interacts with Hedgehog (Hh) signaling pathway and epidermal growth factor receptor (EGFR), which has a wide range of biological functions such as cell proliferation, apoptosis, differentiation, and activation of platelet activity. The current review is a systematic review performed using SCOPUS, Cochrane, and Pubmed/Medline according to The Preferred Reporting Items for Systematic Reviews and Meta-Analysis Protocol (PRISMA-P) guidelines. This review discusses the entanglement of the SCUBE gene’s potential role in human diseases. Examining the role of the SCUBE family sheds new light on platelet aggregationrelated diseases, cancer prognosis, and their pathogenesis.

Keywords

• SCUBE
• Human diseases
• Hedgehog (Hh) pathway

References

1. Tsao KC, Tu CF, Lee SJ, Yang RB. Zebrafish scube1 (Signal Peptide-CUB (Complement ProteinC1r/C1s, Uegf, and Bmp1)-EGF (Epidermal Growth Factor) Domain-containing Protein 1) is involved in primitive hematopoiesis. J Biol Chem 2013;288:5017-26. doi: 10.1074/jbc.M112.375196
2. Bork P, Beckmann G. The CUB domain. A widespread module in developmentally regulated proteins. J Mol Biol 1993; 231: 539-45. doi: 10.1006/jmbi.1993.1305
3. Campbell ID, Baron M, Cooke RM, et al. Structurefunction relationships in epidermal growth factor (EGF) and transforming growth factor – alpha (TGF-a). Biochem Pharmacol 1990;40:35-40. doi: 10.1016/0006-2952(90)90175-k
4. Groenen LC, Nice EC, Burgess AW. Structure-function relationships for the EGF/TGF-a family of mitogens. Growth Factors 1994;235-57. doi: 10.3109/089.771.99409010997
5. Grimmond S, Larder R, Van Hateren N, et al. Clonning, mapping, and expression analysis of a gene encoding a novel mammalian EGF-related protein (SCUBE1). Genomics 2000;15: 74-81. doi: 10.1006/geno.2000.6370
6. Woods IG, Talbot WS. The you gene encodes an EGF-CUB protein essential of hedgehog signaling in zebrafish. PLoS Biol 2005;3:e66. doi: 10.1371/journal.pbio.0030066
7. Kawakami A, Nojima Y, Toyoda A, et al. The zebrafish-secreted matrix protein You/SCUBE2 is implicated in long-range regulation of hedgehog signaling. Curr Biol 2005;15:480-88. doi: 10.1016/j.cub.2005.02.018
8. Johnson JLFA, Hall TE, Dyson JM, et al. SCUBE Activity is necessary for hedgehog singal transduction in vivo. Dev Biol 2012;368:193-202. doi: 10.1016/j.ydbio.2012.05.007

9. Grimmond S, Larder R, Van Hateren N, et al. Cloning, mapping, and expression analysis of a gene encoding a novel mammalian EGF-related protein (SCUBE1). Genomics 2000;70: 74-81. doi: 10.1006/geno.2000.6370
10. Lin YC, Sahoo BK, Gau SS, Yang RB. The biology of SCUBE. J Biomed Sci 2023;30:33. doi: 10.1186/s12929.023.00925-3
11. Yılmaz C, Gülen B, Sönmez E, et al. Serum SCUBE-1 Levels and return of spontaneous circulation following cardiopulmonary resucitation in adult patients. Avicenna J Med 2022; 12:148- 53. doi: 10.1055/s-0042.175.5389
12. Kumar S, Prajapati KS, Gupta S. The multifaceted role of signal peptide-cub-egf domain containing protein (SCUBE) in cancer. Int J Mol Sci 2022;23:10577. doi: 10.3390/ ijms231810577
13. Grimmond S, Larder R, Van Hateren N, et al. Expression of a novel mammalian epidermal growth factor-related gene during mouse neural development. Mech. Dev 2001; 102: 209- 11. doi: 10.1016/s0925-4773(00)00586-4
14. Haworth K, Smith F, Zoupa M, Seppala M, Sharpe PT, Martyn T Cobourne. Expression of the Scube3 epidermal growth factor-related gene during early embryonic development in the mouse. Gene Expr Patterns 2007;7: 630-4. doi: 10.1016/j. modgep.2006.12.004
15. G. Urrútia, X. Bonfill. PRISMA declaration: a proposal to improve the publication of systematic reviews and meta-analyses. Med Clin 2010;135:507-11. doi: 10.1016/j. medcli.2010.01.015
16. Tu CF, Yan YT, Wu SY, et al. Domain and functional analysis of a novel platelet-endothelial cell surface protein, SCUBE1. J Biol Chem 2008; 283:12478-488. doi: 10.1074/jbc.M705872200
17. Yang RB, Ng CK, Wasserman SM, et al. Identification of novel family of cell-surface proteins expressed in human vascular endothelium. J Biol Chem 2002;277:46364-73. doi: 10.1074/ jbc.M207410200
18. Wu BT, Su YH, Tsai MT, Wasserman SM, Topper JN, Yan RB. A novel secreted, cell-surface glycoprotein containing multiple epidermal growth factor-like repeats and one CUB domain is highly expressed in primary osteoblasts and bones. J Biol Chem 2004;37485-90. doi: 10.1074/jbc.M405912200
19. Tu CF, Yan YT, Wu SY, et al. Domain and functional analysis of a novel platelet-endothelial cell surface protein, SCUBE1. J Biol Chem 2008;12478-88. doi: 10.1074/jbc.M705872200
20. Tu CF , Su YH, Huang YN, et al. Localization and characterization of a novel secreted protein SCUBE1 in human platelets. Cardiovasc Res 2006;71:486-495. doi: 10.1016/j. cardiores.2006.04.010
21. Turkmen S, Eryigit U, Karaca U, et al. Diagnostic value of plasma signal peptide-Cub-Egf domain-containing protein-1 (SCUBE-1) in an experimental model of acute ischemic stroke. Am J Emerg Med 2015;33:262-5. doi: 10.1016/j. ajem.2014.11.051
22. Cekic AB, Cekic OG, Aygun A, et al. The diagnostic value of ischemia-modified albumin (IMA) and signal peptide- CUB-EGF domain-containing protein-1 (SCUBE-1) in an experimental model of strangulated mechanical bowel obstruction. J Invest Surg 2022;35:450-6. doi: 10.1080/08941.939.2020.1847218
23. Aköz A, Türkdoğan KA, Çetin NK, et al. Predicting critical duration and reversibility of damage in acute mesenteric ischemia: an experimental study. Ulu Travma Acil Cerrahi Derg 2018;24:507-13. doi: 10.5505/tjtes.2018.69710
24. Sancaktar NC, Altınbaş A, Çekiç B. Protective role of dexmedetomidine on ileum and kidney damage caused by mesenchymal ischaemia in rats. Turk J Anaesthesiol Reanim 2018;46:470-77. doi: 10.5152/TJAR.2018.46244
25. Favre CJ, Mancuso M, Maas K, McLean JW, Baluk P, McDonald DM. Expression of genes involved in vascular development and angiogenesis in endothelial cells of adult lung. Am J Physiol Heart Circ Physiol 2003;285: H1917-38. doi: 10.1152/ ajpheart.00983.2002
26. Dai DF, Thajeb P, Tu CF, et al. Plasma concentration of SCUBE1, a novel platelet protein, is elevated in patients with acute coronary syndrome and ischemic stroke. J Am Coll Cardiol 2008;51:2173-80. doi: 10.1016/j.jacc.2008.01.060
27. Bolayır HA, Kıvrak T, Güneş H, Akaslan D, Şahin O, Bolayır A. The role of SCUBE1 in the development of late stent thrombosis presenting with ST-elevation myocardial infarction. Rev Port Cardiol 2018;37:375-81. doi: 10.1016/j. repc.2017.07.015
28. Guzel M, Dogru MT, Simsek V, et al. Influence of circadian blood pressure alterations on serum sCUBE1 and soluble CD40 ligand levels in patients with essential hypertension. Am J Cardiovasc Dis 2019;9: 42-8.
29. Tekin YB, Erin KB, Yilmaz A. Evaluation of SCUBE1 Levels as a placental dysfunction marker at gestational diabetes. Gynecol Endocrinol 2020;36:417-20. doi: 10.1080/09513.590.2019.1683537
30. Icel E, Icel A, Mertoglu C, et al. Serum SCUBE-1 levels in patients with diabetic retinopathy. Int Opthalmol 2020;40:859- 65. doi: 10.1007/s10792.019.01249-8
31. Turkmen S, Sahin A, Gunaydin M, et al. The value of signal peptide-CUB-EGF domain-containing protein – 1 (SCUBE1) in the diagnosis of pulmonary embolism: A preliminary study. Acad Emerg Med 2015;22: 922-26. doi: 10.1111/acem.12721
32. Dirican N, Duman A, Sağlam G, et al. The diagnostic significance of signal peptide‑complement C1r/C1s, Uegf, and Bmp1‑epidermal growth factor domain‑containing protein‑1 levels in pulmonary embolism. Ann Thorac Med 2016;11:277- 82. doi: 10.4103/1817-1737.191876
33. Sun W, Tang Y, Tai YY, et al. SCUBE1 controls BMPR2- relevant pulmonary endothelial function: implications for diagnostic marker development in pulmonary arterial hypertension. JACC Basic Transl Sci 2020;5:1073-92. doi: 10.1016/j.jacbts.2020.08.010
34. Bilir B, Soysal-Atile N, Bilir BE, et al. Evaluation of SCUBE-1 and sCD40L biomarkers in patients with hypothyroidism due to Hashimoto’s thyroiditis: A single-blind, controlled clinical study. Eur Rev Med Pharmacol Sci 2016;20:407-13.
35. Erem C, Civan N, Coskun H, et al. Signal peptide-CUB-EGF domain-containing protein 1 (SCUBE1) levels in patients with overt and subclinical hyperthyroidism: effects of treatment. Clin Endocrinol 2016;84:919-24. doi: 10.1111/cen.12955
36. Erdoğan M, Findikli HA, Teran IO. A novel biomarker for predicting sepsis mortality SCUBE-1. Medicine 2021;100:e24671. doi: 10.1097/MD.000.000.0000024671
37. Toprak K, Kaplangoray M, Palice A, et al. SCUBE1 is associated with thrombotic complications, disease severity, and in-hospital mortality in COVID-19 patients. Thromb Res 2022;220:100-6. doi: 10.1016/j.thromres.2022.10.016
38. Capkin AA, Demir S, Mentese A, Bulut C, Ayar A. Can signal peptide-CUB-EGF domain-containing protein (SCUBE) levels be a marker of angiogenesis in patients with psoriasis? Arch Dematol Res 2017;309: 203-7. doi: 10.1007/s00403.017.1722-7
39. Uyanikoglu H, Hilali NG, Yardimciel M, Koyuncu I. A new biomarker for the early diagnosis of ovarian torison: SCUBE-1. Clin Exp Reprod Med 2018;45:94-9. doi: 10.5653/ cerm.2018.45.2.94
40. Karagüzel E, Menteşe A, Kazaz IO, et al. SCUBE1: a promising biomarker in renal cell cancer. Int Braz J Urol 2017:43:638-43. doi: 10.1590/S1677-5538.IBJU.2016.0316
41. Mentese A, Fidan E, Sumer AU, et al. Is SCUBE 1 a new biomarker for gastric cancer? Cancer Biomark 2012; 11: 191- 95. doi: 10.3233/CBM-2012-00285
42. Tsai MT, Cheng CJ, Lin YC, et al. Isolation and characterization of a secreted, cell-surface glycoprotein SCUBE2 from humans. Biochem J 2009;422:119-28. doi: 10.1042/BJ20090341
43. Lin YC, Roffler SR, Yan YT, Yang RB. Disruption of SCUBE2 impairs endochondral bone formation. J Bone Miner Res 2015;30:1255-67. doi: 10.1002/jbmr.2451
44. Ali H, Rustam R, Aprilia D, Arizal C, Gusadri IB, Utami PR. Upregulation of SCUBE2 expression in dyslipidemic type 2 diabetes mellitus is associated with endothelin-1. diabetes Metab Syndr 2019;13:2869-72. doi: 10.1016/j. dsx.2019.07.058
45. Cheng CJ, Lin YC, Tsai MT, et al. SCUBE2 Suppresses breast tumor cell proliferation and confers a favorable prognosis in invasive breast cancer. Cancer Res 2009;69:3634-41. doi: 10.1158/0008-5472.CAN-08-3615
46. Chen JH, Kuo KT, Bamodu OA, et al. Upregulated SCUBE2 expression in breast cancer stem cells enhances triple negative breast cancer aggression through modulation of notch signaling and epithelial-to-mesenchymal transition. Exp Cell Res 2018;370:444-53. doi: 10.1016/j.yexcr.2018.07.008
47. Chen Y, Zhou C, Li H, Li H, Li Y. Identifying key genes for nasopharyngeal carcinoma by prioritized consensus differentially expressed genes caused by aberrant methylation. J Cancer 2021;12:874-84. doi: 10.7150/jca.49392
48. Guo E, Liu H, Liu X. Overexpression of SCUBE2 inhibits proliferation, migration, and invasion in glioma cells. Oncol Res 2017;25:437-44. doi: 10.3727/096504016X147.473.35734344
49. Rinne SJ, Sipilä LJ, Sulo P, et al. Candidate Predisposition Variants in Kaposi Sarcoma as Detected by Whole-Genome Sequencing. Open Forum Infect Dis 2019;6:ofz337. doi: 10.1093/ofid/ofz337
50. Song Q, Li C, Feng X, et al. Decreased Expression of SCUBE2 is Associated with Progression and Prognosis in Colorectal Cancer. Oncol Rep 2015;33:1956-64. doi: 10.3892/ or.2015.3790
51. Cheng CJ, Lin YC, Tsai MT, et al. SCUBE2 suppresses breast tumor cell proliferation and confers a favorable prognosis in invasive breast cancer. Cancer Res 2009;69:3634-41. doi: 10.1158/0008-5472.CAN-08-3615
52. Liu M, Zhou S, Wang J, et al. Identification of Genes Associated with Survival of Breast Cancer Patients. Breast Cancer 2019;26:317-25. doi: 10.1007/s12282.018.0926-9
53. Ottley EC, Pell R, Brazier B, et al. Greater Utility of Molecular Subtype Rather Than Epithelial-to-Mesenchymal Transition (EMT) Markers for Prognosis in High-Risk Non-Muscle- Invasive (HGT1) Bladder Cancer. J Patho Clin Res 2020;6:238- 51. doi: 10.1002/cjp2.167
54. Kallarackal J, Burger F, Bianco S, Romualdi A, Schad M. A 3-Gene Biomarker Signature to Predict Response to Taxane- Based Neoadjuvant Chemotherapy in Breast Cancer. PLoS One 2020;15:e0230313. doi: 10.1371/journal.pone.0230313
55. Andres SA, Wittliff JL. Co-expression of Genes with Estrogen Receptor – α and Progesterone Receptor in Human Breast Carcinoma Tissue. Horm Mol Biol Clin Investig 2012;12:377- 90. doi: 10.1515/hmbci-2012-0025
56. Skrzypczak M, Lattrich C, Häring J, Schüler S, Ortmann O, Treeck O. Expression of SCUBE2 Gene Declines in High Grade Endometrial Cancer and Associates with Expression of Steroid Hormone Receptors and Tumor Suppressor PTEN. Gynecol Endocrinol 2013;29:1031-35. doi: 10.3109/09513.590.2013.829441
57. Lin YC, Lee YC, Li LH, Cheng CJ, Yang RB. Tumor Suppressor SCUBE2 Inhibits Breast-Cancer Cell Migration and Invasion Through the Reversal of Epithelial–Mesenchymal Transition. J Cell Sci 2014;127:85-100. doi: 10.1242/jcs.132779
58. Lin YC, Liu CY, Kannagi R, Yang RB. Inhibition of Endothelial SCUBE2 (Signal Peptide-CUB-EGF Domain-Containing Protein 2), a Novel VEGFR2 (Vascular Endothelial Growth Factor Receptor 2) Coreceptor, Suppresses Tumor Angiogenesis. Arterioscler Thromb Vasc Biol 2018;38:1202- 15. doi: 10.1161/ATVBAHA.117.310506
59. Wu BT, Su YH, Tsai MT, Wasserman SM, Topper JN, Yang RB. A Novel Secreted, Cell-Surface Glycoprotein Containing Multiple Epidermal Growth Factor-like Repeats and One CUB Domain Is Highly Expressed in Primary Osteoblasts and Bones. J Biol Chem 2004;37485-90. doi: 10.1074/jbc. M405912200
60. Xavier GM, Economou A, Guimarães ALS, Sharpe PT, Cobourne MT. Characterization of a Mouse Scube3 Reporter Line. Genesis 2010;684-92. doi: 10.1002/dvg.20678
61. Liu X, Wang LG, Zhang LC, et al. Molecular Cloning, Tissue Expression Pattern, and Copy Number Variation of Porcine SCUBE3. Genet Mol Res 2016;15:gmr7010. doi: 10.4238/ gmr.15017010
62. Tu CF, Tsao KC, Lee SJ, Yang RB. SCUBE3 (Signal Peptide- CUB-EGF Domain-containing Protein 3) Modulates Fibroblast Growth Factor Signaling during Fast Muscle Development. J Biol Chem 2014;289:18928-42. doi: 10.1074/ jbc.M114.551929
63. Fuchs H, Sabrautzki S, Przemeck GKH, et al. The First Scube3 Mutant Mouse Line with Pleiotropic Phenotypic Alterations. G3 (Bethesda) 2016;6:4035-46. doi: 10.1534/g3.116.033670
64. Yang HY, Cheng CF, Djoko B, et al. Transgenic Overexpression of The Secreted, Extracellular EGF-CUB Domaincontaining Protein SCUBE3 Induces Cardiac Hypertrophy in Mice. Cardiovasc Res 2007;75:139-147. doi: 10.1016/j. cardiores.2007.03.014
65. Yang X, Hu J, Shi C, Dai J. Activation of TGF-b1 Pathway by SCUBE3 Regulates TWIST1 Expression and Promotes Breast Cancer Progression. Cancer Biother Radiopharm 2020;35:120-28. doi: 10.1089/cbr.2019.2990
66. Gao C, Zhuang J, Li H, et al. Development of a Risk Scoring System for Evaluating the Prognosis of Patients with Her2‑positive Breast Cancer. Cancer Cell Int 2020;20:121. doi: 10.1186/s12935.020.01175-1
67. Huo Q, He X, Li Z, et al. SCUBE3 Serves as An Independent Poor Prognostic Factor in Breast Cancer. Cancer Cell Int 2021;21:268. doi: 10.1186/s12935.021.01947-3
68. Morris MR, Ricketts CJ, Gentle D, et al. Genome-wide Methylation Analysis Identifies Epigenetically Inactivated Candidate Tumour Suppressor Genes in Renal Cell Carcinoma. Oncogene 2011;30:1390-1401. doi: 10.1038/ onc.2010.525
69. Zhao C, Qin Q, Wang Q, et al. SCUBE3 Overexpression Predicts Poor Prognosis in Non-Small Cell Lung Carcinoma. Biosci Trends 2013;7:264-69
70. Wendt FR, Pathak GA, Levey DF, et al. Sex-stratified Geneby- Environment Genome-Wide Interaction Study of Trauma, Posttraumatic-Stress, and Suicidality. Neurobiol Stress 2021;14:100309. doi: 10.1016/j.ynstr.2021.100309